Pharmaceutical companies are walking a tightrope between the need to develop new blockbuster drugs and demand from investors for double-digit returns.
To complicate matters, expiring patents are jeopardizing long-term revenue streams, while soaring R&D and marketing costs erode profit margins. Pharmaceutical companies are having to find new ways to plug product gaps and maintain growth rates.
Given these challenges, today’s pharmaceutical companies need leaders with broad experience, including a background in drug development, commercialization and deal-making. They must have the operational expertise to pursue the most cost-effective processes for developing the pipeline, while balancing market, regulatory and competitive demands.
We understand that human capital is a key element of our clients’ global strategies. Our consultants cross geographic, product and service lines to find the best possible solution for every recruitment assignment. As former executives, doctors of molecular biology and senior managers in many life sciences fields, our consultants bring to each assignment an in-depth knowledge of industry issues, organizations’ cultural nuances and candidates’ strengths.
We have conducted more than 500 assignments for pharmaceutical companies in the past three years, placing CEOs and other senior-level executives as well as key research staff working on the front line of new product discovery.
To discuss your leadership needs, please contact:
Mark Broer, Global Leader, Pharmaceuticals - Emerging Markets & Segments
Bill Clemens, III, Global Leader, Pharmaceuticals